Discovery of the Potent and Selective M1 PAM-Agonist N-[(3 R,4 S)-3-Hydroxytetrahydro-2 H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects
Open accessThe DOI matches its Crossref record.
Abstract
It is hypothesized that selective muscarinic M1 subtype activation could be a strategy to provide cognitive benefits to schizophrenia and Alzheimer's disease patients while minimizing the cholinergic side effects observed with nonselective muscarinic orthosteric agonists. Selective activation of M1 with a positive allosteric modulator (PAM) has emerged as a new approach to achieve selective M1 activation. This manuscript describes the development of a series of M1-selective pyridone and pyridine amides and their key pharmacophores. Compound 38 (PF-06767832) is a high quality M1 selective PAM that has well-aligned physicochemical properties, good brain penetration and pharmacokinetic properties. Extensive safety profiling suggested that despite being devoid of mAChR M2/M3 subtype activity, compound 38 still carries gastrointestinal and cardiovascular side effects. These data provide strong evidence that M1 activation contributes to the cholinergic liabilities that were previously attributed to activation of the M2 and M3 receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Biased Receptor Signaling in Drug Discovery
Kenakin, T. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.016790 · Cited by 294
Self-citationLate-stage Functionalization for Improving Drug-like Molecular Properties
Castellino, N. J., Montgomery, A. P., Danon, J. J., & Kassiou, M. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00797 · Cited by 264
Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs
Hollingsworth, S. A., Kelly, B., Valant, C., Michaelis, J. A., Mastromihalis, O., Thompson, G., Venkatakrishnan, A. J., Hertig, S., Scammells, P. J., Sexton, P. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11062-7 · Cited by 73
Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias
van der Westhuizen, E. T., Choy, K. H. C., Valant, C., McKenzie-Nickson, S., Bradley, S. J., Tobin, A. B., Sexton, P. M., & Christopoulos, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.606656 · Cited by 63
“…2009; Kuduk et al., 2010; Kuduk et al., 2011; Salovich et al., 2012; Le et al., 2013; Mistry et al., 2013; Croy et al., 2014; Huynh et al., 2015; Davoren et al., 2016a; Mistry et al., 2016a; Wood et al., 2016a; Davoren et al., 2016b; Mistry et al., 2016b; Wood et al., 2016b; Wood et al., 2017a;…”
BackgroundInfluentialTargeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
Dwomoh, L., Tejeda, G. S., & Tobin, A. B. (2022) · Neuronal Signaling · doi:10.1042/ns20210004 · Cited by 60
Metadata
- Authors
- Davoren, J. E., Lee, C.-W., Garnsey, M., Brodney, M. A., Cordes, J., Dlugolenski, K., Edgerton, J. R., Harris, A. R., Helal, C. J., Jenkinson, S., Kauffman, G. W., Kenakin, T. P., Lazzaro, J. T., Lotarski, S. M., Mao, Y., Nason, D. M., Northcott, C., Nottebaum, L., O’Neil, S. V., Pettersen, B., Popiolek, M., Reinhart, V., Salomon-Ferrer, R., Steyn, S. J., Webb, D., Zhang, L., & Grimwood, S.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-07-01
- Volume
- 59
- Issue
- 13
- Pages
- 6313-6328
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2414103203
- Cited by
- 85
- References
- 0
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discovery of the Potent and Selective M1 PAM-Agonist N-[(3 R,4 S)-3-Hydroxytetrahydro-2 H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects. https://app.cochat.ai/papers/10.1021/acs.jmedchem.6b00544
- The paper
- Davoren, J. E., Lee, C.-W., Garnsey, M., Brodney, M. A., Cordes, J., Dlugolenski, K., Edgerton, J. R., Harris, A. R., Helal, C. J., Jenkinson, S., Kauffman, G. W., Kenakin, T. P., Lazzaro, J. T., Lotarski, S. M., Mao, Y., Nason, D. M., Northcott, C., Nottebaum, L., O’Neil, S. V., . . . Grimwood, S. (2016). Discovery of the Potent and Selective M1 PAM-Agonist N-[(3 R,4 S)-3-Hydroxytetrahydro-2 H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6b00544
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.